Compound Detail
CHEMBL279229
URAPIDIL 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL279229 |
| Name | URAPIDIL |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | ICMGLRUYEQNHPF-UHFFFAOYSA-N |
3
Targets
3
Activities
2
Assay Types
6
PK Parameters
20
Publications
3
Known Names
4
Indications
Molecular Properties
387.5
MW (Da)
0.72
ALogP
8
HBA
1
HBD
71.7
PSA (Ų)
0.71
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Cerebrovascular Disorders Hypertension Pre-Eclampsia Stroke
ATC Classification
C02CA06
urapidil
Level 1: CARDIOVASCULAR SYSTEM
Level 2: ANTIHYPERTENSIVES
Activity Summary
Ki 2 meas. best 6.89
Kd 1 meas. best 7.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | Kd | 7.1 | 7.1 | 79.4 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 6.89 | 6.89 | 127.9 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 6.67 | 6.67 | 213.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.1 | mL.min-1.kg-1 | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| MRT | 4.0 | hr | Homo sapiens |
| T1/2 | 3.5 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | Kd | = | 79.43 | nM | 7.1 | Antagonistic Alpha-1 adrenergic receptor activity against phenylephrine-induced ... | 10386934 |
| Adrenergic receptor alpha-1 | Ki | = | 127.9 | nM | 6.89 | Displacement of [3H]prazosin from rat cerebral cortex adrenergic receptor alpha1... | 29730027 |
| 5-hydroxytryptamine receptor 1A | Ki | = | 213.0 | nM | 6.67 | Binding affinity to 5-HT1A receptor (unknown origin) | 29730027 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 10891117 | 10.1021/jm0000564 | ADMET | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 10891117 | 10.1021/jm0000564 | No relevant target | 2 |
| 23956101 | 10.1093/toxsci/kft176 | Bile salt export pump | 1 |
| 23956101 | 10.1093/toxsci/kft176 | ATP-binding cassette sub-family C member 2 | 1 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
| 22961681 | 10.1124/dmd.112.047068 | Bile salt export pump | 1 |
Data from ChEMBL 36 via Core Engine